Dr. Bevilacqua an invited speaker at the World Antimicrobial Resistance Congress

WASHINGTON, DC  -  NOVEMBER 7, 2019 - The World Antimicrobial Resistance Congress is one of the world’s largest conferences focused on the global crisis of antimicrobial resistance.  Dr. Michael Bevilacqua, CEO and CSO of Amicrobe, was invited to speak on the topic of working with regulatory authorities in the development of non-traditional products. Dr. Bevilacqua’s presentation entitled “Working with regulators to advance non-traditional therapies to prevent and treat infections in surgery and trauma” was well-received by the antibiotic resistance community.

​

​